CLAUDIA E DUMITRESCU

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism MALONE, NY NPI 1588809602

General Payments — all program years on this page

$2,741.34

  • Category: General Payments
  • Program years: PY2018–2021
  • Record count: 207
  • As of (CMS publication): 2026-01-23

Latest program year (PY2021): $641.08 across 42 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2021) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $639.7639
Education $1.323

By paying entity

Latest program year (PY2021) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $950.1376
2019 $723.7659
2020 $426.3730
2021 $641.0842

Records — PY2021 (42)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
763557704 Boehringer Ingelheim Pharmaceuticals, Inc. $13.35 03/31/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
792504693 IBSA Pharma Inc. $19.49 05/13/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
818902267 Lilly USA, LLC $17.70 02/02/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819016815 Lilly USA, LLC $17.89 02/12/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819018415 Lilly USA, LLC $13.56 01/27/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819018417 Lilly USA, LLC $18.19 06/16/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819018421 Lilly USA, LLC $20.41 07/21/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819019951 Lilly USA, LLC $0.44 02/15/2021 Education Undisputed 01/23/2026 View at CMS
819019955 Lilly USA, LLC $14.24 05/11/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819019959 Lilly USA, LLC $15.60 01/14/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819019963 Lilly USA, LLC $3.71 02/12/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819024821 Lilly USA, LLC $12.87 03/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819029136 Lilly USA, LLC $0.44 01/22/2021 Education Undisputed 01/23/2026 View at CMS
819029139 Lilly USA, LLC $4.35 03/31/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
819030493 Lilly USA, LLC $0.44 02/15/2021 Education Undisputed 01/23/2026 View at CMS
819030497 Lilly USA, LLC $18.13 04/13/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
825229125 Amgen Inc. $16.65 03/16/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836092189 Novo Nordisk Inc $13.58 01/19/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836092191 Novo Nordisk Inc $13.23 01/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836092193 Novo Nordisk Inc $18.70 02/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836092195 Novo Nordisk Inc $24.09 02/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836092197 Novo Nordisk Inc $11.98 04/27/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836092199 Novo Nordisk Inc $15.02 05/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836092201 Novo Nordisk Inc $17.38 06/17/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836113687 Becton, Dickinson and Company $17.75 05/19/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
837419733 Xeris Pharmaceuticals, Inc. $14.85 03/18/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
837419737 Xeris Pharmaceuticals, Inc. $14.46 04/28/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
837419743 Xeris Pharmaceuticals, Inc. $19.98 05/25/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
837419748 Xeris Pharmaceuticals, Inc. $20.71 07/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
837419753 Xeris Pharmaceuticals, Inc. $17.24 08/03/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
837519855 Corcept Therapeutics $15.23 04/14/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
837519857 Corcept Therapeutics $17.30 05/18/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
843609845 SANOFI-AVENTIS U.S. LLC $12.50 02/10/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
843609893 SANOFI-AVENTIS U.S. LLC $23.26 04/21/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
843609987 SANOFI-AVENTIS U.S. LLC $13.75 07/28/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
845275643 DEXCOM, INC. $16.05 02/17/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
845275645 DEXCOM, INC. $23.48 05/05/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
848418249 Merck Sharp & Dohme Corporation $17.86 08/17/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
848418901 Merck Sharp & Dohme Corporation $22.11 02/25/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
848504263 Merck Sharp & Dohme Corporation $19.81 04/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
848701409 Merck Sharp & Dohme Corporation $14.93 03/23/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
848704867 Merck Sharp & Dohme Corporation $18.37 01/26/2021 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.